Company Filing History:
Years Active: 2010-2012
Title: The Innovative Contributions of Denise Lyn Andersen
Introduction
Denise Lyn Andersen is a prominent inventor based in Simi Valley, CA (US). She has made significant contributions to the field of biotechnology, particularly in the development of compounds that target Beta-secretase enzyme activity. With a total of 3 patents to her name, her work is crucial in the fight against Alzheimer's disease and related conditions.
Latest Patents
One of her latest patents focuses on Beta-secretase modulators and methods of use. This invention comprises a new class of compounds that are useful for modulating Beta-secretase enzyme activity. The compounds are designed for the treatment of Beta-secretase mediated diseases, including Alzheimer's disease (AD). In one embodiment, the compounds have a general Formula I, wherein A, B, R, R, R, i, and j are defined. The invention also includes pharmaceutical compositions that incorporate one or more compounds of Formula I. Methods of use for these compounds involve administering them to a subject for the treatment of AD and related diseases. Additionally, the invention encompasses further embodiments of Formulas II and III, intermediates, and processes useful for the preparation of these compounds.
Career Highlights
Denise is currently employed at Amgen Inc., a leading biotechnology company. Her role at Amgen allows her to leverage her expertise in developing innovative solutions for complex medical challenges.
Collaborations
Throughout her career, Denise has collaborated with notable colleagues, including Brian K Albrecht and Michael D Bartberger. These collaborations have further enhanced her research and development efforts in the field.
Conclusion
Denise Lyn Andersen's contributions to biotechnology, particularly in the area of Alzheimer's disease treatment, highlight her innovative spirit and dedication to improving human health. Her work continues to pave the way for advancements in medical science.